DNA X, Inc. SONM
$3.10
$0.082.62%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -119.67% | 171.34% | -86.98% | 36.41% | -1,732.10% |
| Total Depreciation and Amortization | -- | -- | 57.14% | 19.45% | -24.45% |
| Total Amortization of Deferred Charges | -200.00% | -95.63% | -- | -100.00% | 2,443.90% |
| Total Other Non-Cash Items | 101.13% | -6,913.95% | -170.26% | -63.57% | 116.54% |
| Change in Net Operating Assets | -119.40% | 13.27% | 230.49% | -3,967.82% | 98.57% |
| Cash from Operations | 42.27% | -72.95% | 71.51% | -44.08% | 49.18% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -102.80% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -45.69% | 4,649.02% | -101.80% |
| Total Debt Repaid | -- | -- | -- | 100.00% | -- |
| Issuance of Common Stock | -- | -- | -102.60% | -10.53% | 53.10% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -83.67% | 50.12% | -25.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -173.15% | 87.05% | -736.64% | 220.18% | 96.62% |